So, it is speculated that the function of mTORC1 may be changed from promoting cell proliferation to enhancing cell osteo-/odontogenic differentiation when Foxc2 and BMP2 were both activated in SCAP. The gene discussed is FOXC2; the disease is syringocystadenoma papilliferum.